Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024. 

"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."

Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month. 

The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses. 

Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent. 

Share:
More In Business
Egg Prices See Largest Monthly Decline in 72 Years
The price of one kitchen staple is dropping at a historic rate. In May, egg prices had their largest monthly decline in 72 years. Ricky Richardson, CEO of South Carolina-based Eggs Up Grill, joined Cheddar News to discuss the state of play in the egg industry as prices fall while food costs overall are on the rise again. Egg prices are "returning to more normal levels now, we're running down about 40% on a year-over-year basis," he said.
Load More